MedTrace Logo

Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction

NCT03382665 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-04-07

Study results available
· View outcomes & findings →

Summary

The study is a multi-center, prospective, non-controlled, consecutive cohort post market surveillance study. The objective of this study is to obtain survival and clinical outcome data on the Hyperion® system in primary and revision total hip arthroplasty.

Conditions

  • Osteoarthritis
  • Avascular Necrosis
  • Rheumatoid Arthritis
  • Functional Deformities
  • Pseudoarthrosis
  • Revision of Endoprosthesis-treated Hips
  • Fracture, Proximal Humeral
  • Provision of Non-endoprosthetic Previous Operations of the Hip Joint (e.g., Transposition Osteotomies)
  • Femur Fracture
  • Pseudarthrosis
  • Trochanteric Fractures
  • Bridging of Large Bone Defects
  • Revisions

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Paola Vivoda · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2017-08-31
Completion
2018-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03382665 on ClinicalTrials.gov